Maternal & Child Health Research Institute (MCHRI)


Showing 51-60 of 64 Results

  • Jonathan Z. Long

    Jonathan Z. Long

    Associate Professor of Pathology

    BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies the molecular mechanisms of mammalian energy homeostasis. Dr. Long is the recipient of the Alfred P. Sloan Research Fellowship in Chemistry, the Breakthrough Sciences Award from the Ono Pharma Foundation, and the NIDDK Catalyst Award. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.

  • Dr. Michael T. Longaker

    Dr. Michael T. Longaker

    Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Materials Science and Engineering

    Current Research and Scholarly InterestsWe have six main areas of current interest: 1) Cranial Suture Developmental Biology, 2) Distraction Osteogenesis, 3) Fibroblast heterogeneity and fibrosis repair, 4) Scarless Fetal Wound Healing, 5) Skeletal Stem Cells, 6) Novel Gene and Stem Cell Therapeutic Approaches.

  • Billy W Loo Jr, MD PhD FASTRO FACR

    Billy W Loo Jr, MD PhD FASTRO FACR

    Professor of Radiation Oncology (Radiation Therapy)

    Current Research and Scholarly InterestsMy clinical specialty is precision targeted radiotherapy of thoracic cancers.

    My research is on developing next-generation ultra-rapid radiotherapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.

    My clinical research is on advanced 4-D image-guided radiotherapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.

  • Alarice Cheng-Yi Lowe

    Alarice Cheng-Yi Lowe

    Associate Professor of Pathology

    BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.

  • Lu,Guolan

    Lu,Guolan

    Assistant Professor of Urology

    Current Research and Scholarly InterestsThe Lu Lab develops and integrates AI, spatial multi-omics, and advanced imaging to understand and model how cells, tissues, and therapeutic agents interact in their native spatial context, and how these interactions drive disease progression and treatment response.

  • Sydney X. Lu

    Sydney X. Lu

    Assistant Professor of Medicine (Hematology)

    BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.

    As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.

    Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute.

  • Stephen Luby

    Stephen Luby

    Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.

  • Chase A. Ludwig, MD, MS

    Chase A. Ludwig, MD, MS

    Assistant Professor of Ophthalmology (Research/Clinical Trials)

    Current Research and Scholarly InterestsMy research focuses on understanding high and pathologic myopia and their retinal sequelae, including retinal detachments, myopic traction maculopathy, and myopic macular degeneration. By leveraging informatics and big data analytics, I aim to uncover strategies that prevent and treat the progression of these complex and devastating conditions. My work takes advantage of the retina’s unique role as the only visible portion of the central nervous system, allowing for discoveries in ophthalmology that have the potential to impact broader fields of medicine.

    I am actively seeking medical students and residents interested in ophthalmology or vitreoretinal surgery to assist with writing projects and data analytics. If you are passionate about advancing the understanding and management of myopia, I invite you to join me in tackling one of the most pressing global challenges in eye care.